SCHEMBL6983879

SCHEMBL6983879

CCOC(=O)Cc1ccccc1S(=O)(=O)Nc1ccc2ncccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
LMNA P02545 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
ALOX5 P09917 2/20 0.47
NOTUM Q6P988 1/20 0.46
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
NPC1 O15118 2/20 0.44
POLB P06746 2/20 0.44
MAPT P10636 2/20 0.44
NAMPT P43490 1/20 0.43
RAB9A P51151 2/20 0.43
PABPC1 P11940 1/20 0.42
PKM P14618 1/20 0.42
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984890 0.78 ALDH1A1 (0.67) ALDH1A1LMNASMN1; SMN2NOTUMKMT2A
SCHEMBL7956821 0.77 SMN1; SMN2 (0.53) ALDH1A1LMNASMN1; SMN2KMT2AMEN1
SCHEMBL1193623 0.75 ALOX5 (0.56) ALDH1A1LMNASMN1; SMN2ALOX5NOTUM
SCHEMBL6979787 0.74 BRD4 (0.39) ALDH1A1LMNAPOLBMAPTPKM
SCHEMBL6981195 0.73 ALDH1A1 (0.60) ALDH1A1LMNASMN1; SMN2KMT2AMEN1
SCHEMBL6635935 0.73 PPARG (0.46) ALDH1A1LMNASMN1; SMN2KMT2AMEN1
SCHEMBL4701042 0.73 HDAC3 (0.52) ALDH1A1SMN1; SMN2ALOX5NOTUMNPC1
SCHEMBL14346079 0.72 KDM4E (0.46) ALDH1A1LMNAALOX5NOTUMKMT2A
SCHEMBL5342156 0.72 SLC40A1 (0.62) ALDH1A1LMNASMN1; SMN2KMT2AMEN1
SCHEMBL27700676 0.71 ALDH1A1 (0.63) ALDH1A1LMNASMN1; SMN2NOTUMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed